Status | Study |
Completed |
Study Name: Clinical Specimens Testing Program of Dengue Antigen Detection Reagents Condition: Dengue Fever Date: 2012-09-28 |
Active, not recruiting |
Study Name: A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults Condition: Dengue Fever Date: 2012-08-08 Interventions: Biological: 4 µg TDENV-PIV with Alum adjuvant |
Completed |
Study Name: Celgosivir as a Treatment Against Dengue Condition: Dengue Fever Date: 2012-05-15 Interventions: Drug: celgosivir 100 mg capsul |
Completed |
Study Name: International Research Consortium on Dengue Risk Assessment, Management, and Surveillance Condition: Dengue Fever Date: 2012-03-07 Interventions: Other: Observation Clinical follow-up and laboratory investigations. |
Completed |
Study Name: Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue Disease Condition: Dengue Fever Date: 2011-12-16 Interventions: Biological: DENV-1 PIV, 2.5 µg |
Completed |
Study Name: Role of Andi-d in Dengue Fever: a Pilot Study Condition: Dengue Fever Date: 2011-09-25 Interventions: Drug: anti-d intervention group received injection anti-d in dose of 50 µg/kg (250IU/kg) along with |
Completed |
Study Name: Laboratory Diagnosis and Prognosis of Severe Dengue Condition: Dengue Fever Date: 2011-08-22 |
Completed |
Study Name: Adult Dengue Platelet Study Condition: Dengue Fever Date: 2009-11-03 Interventions: Procedure: Platelet transfusion |
Completed |
Study Name: Diagnosis and Characterization of Dengue Fever in Children Condition: Dengue Fever Date: 2009-07-22 |
Completed |
Study Name: Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue Vaccine Condition: Dengue Fever Date: 2009-06-11 Interventions: Biological: rDEN2/4delta30(ME) vaccine |